Sterile Packaging And Supply Chain Traceability Management For Tuohy Epidural Needles

https://en.wikipedia.org/wiki/Tuohy_needle

In the extensive journey of the Tuohy epidural needle​ from factory to operating room, sterilization and packaging serve as the guardians of the final sterile barrier, while supply chain traceability acts as a lifeline for managing medical device adverse events. Our manufacturing workflow does not transition directly to logistics after needle fabrication; instead, it enters controlled packaging and sterilization suites. Here, environmental parameters, material selection, and process design directly determine the safety baseline when the product reaches clinical use.

As a Class III invasive device penetrating the spinal canal, the Tuohy epidural needle​ must guarantee sterility (SAL 1×10⁻⁶) for a single use cycle. Current industry-standard sterilization methods include Ethylene Oxide (EO) gas sterilization and Cobalt-60 Gamma Irradiation. EO sterilization is suitable for heat-sensitive assemblies (e.g., plastic-winged hubs) but requires strict residual control. Gamma irradiation leaves no residues and offers deep penetration but may cause discoloration or embrittlement in certain polymers. We configure processes flexibly based on client orders: for all-metal Tuohy epidural needles​ (no plastic components), we recommend irradiation to shorten aeration cycles; for needles with PVC/PC hubs, we utilize EO sterilization followed by a 7–14 day aeration period until EO residuals fall below 0.1mg/unit (per YY/T 1300).

The packaging system comprises primary and secondary packaging. Primary packaging contacts the product directly, typically utilizing Tyvek® (DuPont) paired with medical-grade dialysis paper pouches. These materials offer bacterial barrier properties, breathability (facilitating EO penetration and aeration), and peelability without fiber shedding. On our automated packaging lines, we set precise sealing temperature, pressure, and dwell time parameters. Every batch undergoes dye penetration tests and burst testing. Individually packed Tuohy epidural needles​ may feature integrated sterilization indicators (e.g., EO or radiation-sensitive ink strips) allowing clinicians to visually verify sterilization efficacy upon opening. Secondary packaging (corrugated cartons) is customized to client specifications-using standard export boxes or reusable plastic totes-with desiccants and shock-absorbing foam inserts to protect against humidity fluctuations and transit shocks during international shipping.

Regarding traceability, ISO 13485 mandates a Unique Device Identification (UDI) system spanning from raw materials to end-user delivery. During laser marking, our Tuohy epidural needles​ receive lot numbers, manufacturing dates, expiry dates, and serial numbers (if requested) directly on the shaft or packaging. Should market feedback indicate a physical defect (e.g., hub cracking, illegible markings) in a specific batch, we can retrieve raw material inspection records, process logs, sterilization curves, and shipping manifests within two hours, enabling precise impact assessment and recall execution. This "forward traceable, backward traceable" capability is the compliance bedrock for modern medical device manufacturers.

Moreover, for customized orders (e.g., proprietary gauges developed from client 2D/3D drawings), we maintain supplementary archives including First Article Inspection (FAI) reports, mold change records, and customer-signed golden samples. Even years later, repeat orders for the same Tuohy epidural needle​ specification guarantee consistency in material, surface finish, and tolerances. Amidst tightening global regulations (e.g., China NMPA's 2025 Guidelines for Registration Review of Single-use Anesthetic Needles), robust sterilization, packaging, and traceability systems are no longer merely certification hurdles-they are the commercial bedrock for earning clinical trust.